http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd6e9bb8bc3c69e28c105638862e762c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Palanisamy |
| name | Nallasivam Palanisamy |
| given-name | Nallasivam |
| organization-name | 1Michigan Center for Translational Pathology,; 3Pathology and Department of Urology, Henry Ford Health Detroit, MI 48202, USA. Michigan Center for Translational Pathology University of Michigan Medical School Ann Arbor Michigan; Department of Urology Henry Ford Health System Detroit Michigan From the Cell Biology Program, the Immunology Program, and the Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY. 8Department of Urology, Henry Ford Health System, Detroit, Michigan. Michigan Center for Translational Pathology, University of Michigan, Ann Arbor Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Department of Urology Vattikuti Urology Institute Henry Ford Health System Detroit MI USA Authors' Affiliations: 1Department of Pathology and Immunology, Baylor College of Medicine; 2Michael E. DeBakey Department of Veterans Affairs Medical Center, Houston, Texas; and 3Michigan Center for Translational Pathology and Department of Pathology, University of Michigan, Ann Arbor, Michigan Authors' Affiliation: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan Michigan Center for Translational Pathology University of Michigan Ann Arbor Michigan Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Michigan Center for Translational Pathology University of Michigan Medical School Ann Arbor MI 48109 USA; Comprehensive Cancer Center University of Michigan Medical School Ann Arbor MI 48109 USA Department of Pathology University of Michigan Medical School Ann Arbor Michigan; Department of Urology University of Michigan Medical School Ann Arbor Michigan; Comprehensive Cancer Center University of Michigan Medical School Ann Arbor Michigan Michigan Center for Translational Pathology; Department of Pathology, University of Michigan; Comprehensive Cancer Center, University of Michigan Medical School; Shared senior authors 3Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. Authors' Affiliations: 1Cellular and Molecular Research and 2Division of Medical Oncology, National Cancer Centre of Singapore; 3Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School; 4Genome Institute of Singapore; 5Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; and 6Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seodaemun-Ku, Seoul, Korea Genome Institute of Singapore, 60 Biopolis Street, Genome 02-01, Singapore 138672, Singapore. Departments of aPathology,; Michigan Center for Translational Pathology and; Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI 48109; Vattikutti Urology Institute Henry Ford Health System Detroit MI USA; Michigan Center for Translational Pathology University of Michigan Ann Arbor MI USA Michigan Center for Translational Pathology, Ann Arbor, MI 48109;; Departments of bPathology and Pathology, University of Michigan Medical Center, Ann Arbor 1Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan.; 2Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.; 5Department of Urology, Henry Ford Health System, Detroit, Michigan. Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA. Department of Urology, Henry Ford Health System, Detroit, MI, USA Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, Henry Ford Health System, Detroit, MI 48202, USA Michigan Center for Translational Pathology, University of Michigan Health System, Ann Arbor MI; and; Department of Urology, Vattikutti Urology Institute, Henry Ford Health System, Detroit, MI. From the Cell Biology Program, Departments of Epidemiology and Biostatistics, Medicine, and Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; the Institute for Cancer Genetics, Columbia University, New York, NY; and Cancer Genetics Inc, Milford, MA. Department of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA. nallasiv@med.umich.edu Josephine Ford Cancer Institute; Department of Urology, Vattikutti Urology Institute, Henry Ford Health System; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI Henry Ford Health System, Detroit, Michigan, USA 3Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan.; 6Department of Pathology, University of Michigan, Ann Arbor, Michigan. Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA 7Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. Michigan Center for Translational Pathology and Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. Henry Ford Health System, Detroit, MI, USA; University of Michigan, Ann Arbor, MI, USA 1Michigan Center for Translational Pathology, University of Michigan Health System, Ann Arbor, Michigan.; 2Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan.; 4Department of Urology, Henry Ford Health System, Detroit, Michigan. Department of Urology, Henry Ford Health System, Detroit, MI 48202, USA Henry Ford Health System 1 Ford Place Detroit MI 48202 USA Department of Urology Henry Ford Health System Detroit MI USA; Department of Pathology University of Michigan Ann Arbor MI USA Department of Urology, Henry Ford Health System, Detroit, MI Department of Pathology University of Michigan Ann Arbor MI USA; Michigan Center for Translational Pathology University of Michigan Ann Arbor MI USA Cell Biology Program (N.P., P.H.R., R.S.K.C.), Memorial Sloan-Kettering Cancer Center, New York, New York 10021; Authors' Affiliations: 1Michigan Center for Translational Pathology, 2National Center for Integrative Biomedical Informatics, Center for Computational Medicine and Bioinformatics, and 3Departments of Pathology and 5Urology, 4Howard Hughes Medical Institute, and 6Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan; 7Departments of Pathology and Laboratory Medicine and 8Urology, Weill Cornell Medical College, and 11Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Beth Israel Deaconess Medical Center, Division of Signal Transduction, and Departments of Medicine and 10Systems Biology, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Michigan Center for Translational Pathology, 2National Center for Integrative Biomedical Informatics, Center for Computational Medicine and Bioinformatics, and 3Departments of Pathology and 5Urology, 4Howard Hughes Medical Institute, and 6Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan; 7Departments of Pathology and Laboratory Medicine and 8Urology, Weill Cornell Medical College, and 11Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Beth Israel Deaconess Medical Center, Division of Signal Transduction, and Departments of Medicine and 10Systems Biology, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Michigan Center for Translational Pathology, 2National Center for Integrative Biomedical Informatics, Center for Computational Medicine and Bioinformatics, and 3Departments of Pathology and 5Urology, 4Howard Hughes Medical Institute, and 6Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan; 7Departments of Pathology and Laboratory Medicine and 8Urology, Weill Cornell Medical College, and 11Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; 9Beth Israel Deaconess Medical Center, Division of Signal Transduction, and Departments of Medicine and 10Systems Biology, Harvard Medical School, Boston, Massachusetts From the Departments of Pathology (Drs Pletneva, Andea, Palanisamy, Betz, Wang, Patel, Fullen, and Harms, and Ms Carskadon) and Dermatology (Drs Andea Patel, Fullen, and Harms), and the Michigan Center for Translational Pathology (Drs Palanisamy and Harms, and Ms Carskadon), University of Michigan Medical Center, Ann Arbor. Genome Institute of Singapore, Singapore Michigan Center for Translational Pathology, University of Michigan Ann Arbor Michigan Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Genome Institute of Singapore, 60 Biopolis Street, 02-01, Genome, Singapore 138672, Singapore. Michigan Center for Translational Pathology; University of Michigan Medical School; Ann Arbor Michigan |
Incoming Links
Total number of triples: 177.